Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
2/2022
vol. 124 abstract:
Review article
Ophthalmic applications of cyclopentolate
Anna Chmielarz-Czarnocińska
1
,
Anna Gotz-Więckowska
1
KLINIKA OCZNA 2022; 124, 2: 71-74
Online publish date: 2022/06/14
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Cyclopentolate is a drug that causes paralysis of accommodation and induces mydriasis. It is widely used around the world. In view of its relatively short duration of action and effective induction of cycloplegia, cyclopentolate is particularly useful in screening children for refractive errors. In addition to diagnostic applications, it is also used for therapeutic purposes, e.g. in uveitis. In October 2021, cyclopentolate, which had not been approved in Poland for years, was authorized for marketing.
The authors of the paper reviewed the literature on cyclopentolate. The properties of the drug were analyzed, and its action was compared with other available cycloplegic agents. In addition, the potential uses of cyclopentolate and its special role in facilitating the ophthalmological examination of children were discussed. keywords:
cyclopentolate, tropicamide, atropine, cycloplegia, refraction assessment after accommodation paralysis, uveitis |
|